145 related articles for article (PubMed ID: 37875278)
1. Successful perinatal management of a woman with congenital factor XIII deficiency using recombinant factor XIII: A case report and literature review.
Ito Y; Tsuji S; Kasahara M; Tokoro S; Murakami T; Takayama H
J Obstet Gynaecol Res; 2024 Feb; 50(2):262-265. PubMed ID: 37875278
[TBL] [Abstract][Full Text] [Related]
2. Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII Deficiency.
Abdel-Samad N
Am J Case Rep; 2017 Apr; 18():436-439. PubMed ID: 28432284
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor XIII A-subunit in a patient with factor XIII deficiency and recurrent pregnancy loss.
Al-Khabori M; Pathare A; Menegatti M; Peyvandi F
J Thromb Haemost; 2018 Jun; 16(6):1052-1054. PubMed ID: 29665207
[TBL] [Abstract][Full Text] [Related]
4. Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and Successes.
Carcao M; Fukutake K; Inbal A; Kerlin B; Lassila R; Oldenburg J; Garly ML; Nugent D
Semin Thromb Hemost; 2017 Feb; 43(1):59-68. PubMed ID: 27556350
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results.
Kerlin BA; Inbal A; Will A; Williams M; Garly ML; Jacobsen L; Kearney SL
J Thromb Haemost; 2017 Aug; 15(8):1601-1606. PubMed ID: 28581691
[TBL] [Abstract][Full Text] [Related]
6. Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency.
Lovejoy AE; Reynolds TC; Visich JE; Butine MD; Young G; Belvedere MA; Blain RC; Pederson SM; Ishak LM; Nugent DJ
Blood; 2006 Jul; 108(1):57-62. PubMed ID: 16556896
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of recombinant factor XIII in young children with congenital FXIII deficiency and comparison with older patients.
Williams M; Will A; Stenmo C; Rosholm A; Tehranchi R
Haemophilia; 2014 Jan; 20(1):99-105. PubMed ID: 23834599
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiency.
Kerlin B; Brand B; Inbal A; Halimeh S; Nugent D; Lundblad M; Tehranchi R
J Thromb Haemost; 2014 Dec; 12(12):2038-43. PubMed ID: 25263390
[TBL] [Abstract][Full Text] [Related]
9. An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy.
Dargaud Y; de Mazancourt P; Rugeri L; Hanss M; Borg JY; Gaucherand P; Negrier C; Trzeciak C
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):447-52. PubMed ID: 18600098
[TBL] [Abstract][Full Text] [Related]
10. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R
Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939
[TBL] [Abstract][Full Text] [Related]
11. Comparison of F13A1 gene mutations in 73 patients treated with recombinant FXIII-A
Ivaškevičius V; Biswas A; Garly ML; Oldenburg J
Haemophilia; 2017 May; 23(3):e194-e203. PubMed ID: 28520207
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic characterization of recombinant factor XIII (FXIII)-A2 across age groups in patients with FXIII A-subunit congenital deficiency.
Brand-Staufer B; Carcao M; Kerlin BA; Will A; Williams M; Tornøe CW; Sandberg Lundblad M; Nugent D
Haemophilia; 2015 May; 21(3):380-385. PubMed ID: 25643920
[TBL] [Abstract][Full Text] [Related]
13. Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency.
Cojutti PG; Zanon E; Pasca S; Pea F;
Clin Pharmacokinet; 2022 Apr; 61(4):505-513. PubMed ID: 34718987
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation factor XIII and factor XIII deficiency.
Dorgalaleh A; Rashidpanah J
Blood Rev; 2016 Nov; 30(6):461-475. PubMed ID: 27344554
[TBL] [Abstract][Full Text] [Related]
15. [Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy].
Takahashi T; Hatao K; Suzukawa M; Oji T
Rinsho Ketsueki; 2007 May; 48(5):418-20. PubMed ID: 17571589
[TBL] [Abstract][Full Text] [Related]
16. Patient-centered approach to managing factor XIII deficiency.
Iyengar V; Montcrieff C; Pels S
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34531230
[TBL] [Abstract][Full Text] [Related]
17. Tailored prophylaxis with rFXIII (NovoThirteen
Zanon E; Pasca S; Radu C; Scattolo N; Spiezia L; Simioni P
Haemophilia; 2019 May; 25(3):e206-e208. PubMed ID: 30888101
[No Abstract] [Full Text] [Related]
18. Minimal factor XIII activity level to prevent major spontaneous bleeds.
Menegatti M; Palla R; Boscarino M; Bucciarelli P; Muszbek L; Katona E; Makris M; Peyvandi F;
J Thromb Haemost; 2017 Sep; 15(9):1728-1736. PubMed ID: 28688221
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Ashley C; Chang E; Davis J; Mangione A; Frame V; Nugent DJ
Haemophilia; 2015 Jan; 21(1):102-8. PubMed ID: 25377187
[TBL] [Abstract][Full Text] [Related]
20. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery.
Kobayashi T; Terao T; Kojima T; Takamatsu J; Kamiya T; Saito H
Gynecol Obstet Invest; 1990; 29(3):235-8. PubMed ID: 2358199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
